When combining thecut-off values for serum IL-8 and GRO-α, none of the MS patients, but 60% ofAQP4-Ab positive patients and 63% of MOG-Ab positive patients had increasedvalues. This evidence concerns the gene CXCL8 and myeloid sarcoma.